Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Universal Insurance Holdings Inc is an insurance-property & casualty business based in the US. Universal Insurance shares (UVE) are listed on the NYSE and all prices are listed in US Dollars. Universal Insurance employs 909 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$13.53|
|52-week range||$11.36 - $16.20|
|50-day moving average||$13.42|
|200-day moving average||$13.86|
|Wall St. target price||$15.00|
|Dividend yield||$0.64 (4.72%)|
|Earnings per share (TTM)||$0.88|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-1.31%|
|1 month (2021-09-16)||5.05%|
|3 months (2021-07-16)||-1.46%|
|6 months (2021-04-16)||-3.29%|
|1 year (2020-10-16)||-5.52%|
|2 years (2019-10-16)||-52.46%|
|3 years (2018-10-16)||45.95|
|5 years (2016-10-14)||22.8|
Valuing Universal Insurance stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Universal Insurance's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Universal Insurance's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Universal Insurance shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Universal Insurance's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $40.7 million.
The EBITDA is a measure of a Universal Insurance's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.1 billion|
|Operating margin TTM||3.17%|
|Gross profit TTM||$314 million|
|Return on assets TTM||1.02%|
|Return on equity TTM||5.45%|
|Market capitalisation||$428.7 million|
TTM: trailing 12 months
There are currently 601,150 Universal Insurance shares held short by investors – that's known as Universal Insurance's "short interest". This figure is 4.8% up from 573,620 last month.
There are a few different ways that this level of interest in shorting Universal Insurance shares can be evaluated.
Universal Insurance's "short interest ratio" (SIR) is the quantity of Universal Insurance shares currently shorted divided by the average quantity of Universal Insurance shares traded daily (recently around 120470.94188377). Universal Insurance's SIR currently stands at 4.99. In other words for every 100,000 Universal Insurance shares traded daily on the market, roughly 4990 shares are currently held short.
However Universal Insurance's short interest can also be evaluated against the total number of Universal Insurance shares, or, against the total number of tradable Universal Insurance shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Universal Insurance's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Universal Insurance shares in existence, roughly 20 shares are currently held short) or 0.0213% of the tradable shares (for every 100,000 tradable Universal Insurance shares, roughly 21 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Universal Insurance.
Find out more about how you can short Universal Insurance stock.
Dividend payout ratio: 70.33% of net profits
Recently Universal Insurance has paid out, on average, around 70.33% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.67% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Universal Insurance shareholders could enjoy a 4.67% return on their shares, in the form of dividend payments. In Universal Insurance's case, that would currently equate to about $0.64 per share.
Universal Insurance's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Universal Insurance's most recent dividend payout was on 8 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 July 2021 (the "ex-dividend date").
Universal Insurance's shares were split on a 1:4 basis on 5 December 1994. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Universal Insurance shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Universal Insurance shares which in turn could have impacted Universal Insurance's share price.
Over the last 12 months, Universal Insurance's shares have ranged in value from as little as $11.3611 up to $16.1964. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Universal Insurance's is 1.0598. This would suggest that Universal Insurance's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Universal Insurance Holdings, Inc. , together with its subsidiaries, operates as an integrated insurance holding company in the United States. The company develops, markets, and underwrites insurance products for personal residential insurance, such as homeowners, renters/tenants, condo unit owners, and dwelling/fire; allied lines, coverage for other structures, and personal property; and commercial residential multi-peril, as well as liability and personal articles coverages. The company also advises on actuarial issues, oversees distribution, administers claims payments, performs policy administration and underwriting, and assists with reinsurance negotiations; places and manages reinsurance programs for the insurance entities; and operates Clovered, in which consumers receive side-by-side quotes from multiple carriers across multiple states, as well as educational materials about homeowners insurance policies. It offers its products through a network of independent agents, as well as Universal Direct, a direct-to-consumer online platform, which enables homeowners to directly purchase, pay for, and bind homeowners' policies. The company was formerly known as Universal Heights, Inc. and changed its name to Universal Insurance Holdings, Inc.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.